Tinzaparin Versus Dalteparin for Perioperative Thromboembolic Prophylaxis in Patients With Dialysis Dependent Renal Disease- A Canadian Multicentre Trial.

Trial Profile

Tinzaparin Versus Dalteparin for Perioperative Thromboembolic Prophylaxis in Patients With Dialysis Dependent Renal Disease- A Canadian Multicentre Trial.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 12 Sep 2014

At a glance

  • Drugs Tinzaparin sodium (Primary) ; Dalteparin sodium
  • Indications Thromboembolism
  • Focus Pharmacodynamics
  • Most Recent Events

    • 02 Dec 2009 Results presented at the 51st Annual Meeting and Exposition of the American Society of Hematology.
    • 14 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 14 Jul 2009 Planned end date changed from Sep 2007 to Dec 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top